Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from…
stemadminStem Cell ResearchNo comments

Aileron Therapeutics, Inc. New ex vivo data demonstrates protection against cyclophosphamide-induced damage to hair follicles and their stem cells Encore presentation of data presented at Society for Investigative Dermatology in May 2022 shows: ALRN-6924 temporarily arrested the cell cycle in human scalp hair follicles and their stem cells Ex vivo data demonstrated protection against taxane-induced damage to hair follicles and their stem cells Nearly all breast cancer patients receiving neoadjuvant or adjuvant chemotherapy, including cyclophosphamide and taxanes, such as docetaxel, experience alopecia (hair loss) Aileron is evaluating ALRN-6924 as a novel chemoprotective agent to prevent chemotherapy-induced bone marrow toxicities and alopecia in its ongoing Phase 1b breast cancer trial BOSTON, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients lives, today announced an oral presentation at the European Society for Dermatological Research (ESDR) Annual Meeting, taking place September 28 October 1, 2022 in Amsterdam. This presentation includes non-clinical data initially presented at the Society for Investigative Dermatology in May 2022 as well as new non-clinical data developed in collaboration with Professor Ralf Paus, M.D., DSc, FRSB and his colleagues at the Dr.

Read more
Exciting Research Part of NASAs SpaceX Crew-5 Mission NASAs SpaceX Crew-5 Mission – NASA Blogs
stemadminStem Cell ResearchNo comments

The iconic countdown clock appears in the foreground, while the Falcon 9 rocket and Dragon spacecraft are seen in the background at NASAs Kennedy Space Center on Wednesday, Oct. 5, 2022. The mission is set to lift off today at noon EDT from the Florida spaceport. Credit: NASA Crew-5 astronauts will conduct new scientific research, including cardiac experiments to prepare for human exploration beyond low-Earth orbit and benefit life on Earth.

Read more
The Global Cell and Gene Therapy Market is expected to grow by $9.97 bn during 2022-2026, accelerating at a CAGR of 20.15% during the forecast period…
stemadminStem Cell ResearchNo comments

ReportLinker Global Cell And Gene Therapy Market 2022-2026 The analyst has been monitoring the cell and gene therapy market and it is poised to grow by $9. 97 bn during 2022-2026, accelerating at a CAGR of 20. New York, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cell and Gene Therapy Market 2022-2026" - https://www.reportlinker.com/p06325351/?utm_source=GNW 15% during the forecast period

Read more
Research Looks to Improve Outcomes in TP53-Mutant AML and MDS – Targeted Oncology
stemadminStem Cell ResearchNo comments

Melhem Solh, MD, discusses his research on post-transplant outcomes of patients with TP53-mutant acute myeloid leukemia and myelodysplastic syndrome. Melhem Solh, MD, medical director for the Cellular Therapy Program at Northside Hospital, discusses his research on post-transplant outcomes of patients with TP53-mutant acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Investigators, including Solh, examined 30 patients to evaluate overall survival (OS), relapse and non-relapse mortality, and disease-free survival (DFS) in patients with AML or MDS with a TP53 mutation and who had underwent an allogeneic hematopoietic stem cell transplant for this indication.

Read more
20220927 Seven New CSL Global Research Acceleration Initiative Awardees Announced – CSL Limited
stemadminStem Cell ResearchNo comments

MELBOURNE, AUSTRALIA - 27 September 2022:Seven medical researchers have been awarded a CSL Research Acceleration Initiative (RAI) partnership, including up to an AU$500,000 investment in each program over two years, to fast-track the discovery of innovative biotherapies to address unmet medical needs. The CSL Research Acceleration Initiative establishes partnerships between CSL and global research organisations to accelerate commercialisation of promising discovery programs. In addition to creating long-term mutual partnerships to further innovation, the initiative includes funding as well as access to CSL R&D experts. The seven Global RAI awardees, selected via the 2021 call for proposals, include researchers from: The University of Queensland, University of Newcastle and ANZAC Research Institute in Australia; University of Pennsylvania in the US; Justus Liebig University Giessen and University Hospital of Ludwig Maximilian University of Munich in Germany; and University of Basel in Switzerland.

Read more
Stem Cell Assay Market Size And Forecast To 2022 |Thermo Fisher Scientific, Perkinelmer, Stemcell Technologies, Merck, Bio-Rad Laboratories The Colby…
stemadminStem Cell ResearchNo comments

Los Angeles, USA: A recent report published by Verified Market Research, titled [Global Stem Cell Assay Market, History and Forecasts for 2022-2029, data broken down by manufacturers, key regions, types and applications], contains an in-depth analysis of the Global Stem Cell Assay Market. The research report is divided in such a way as to highlight the key areas of the market and give the reader a complete picture. The report examines various aspects of the Stem Cell Assay market, such as its opportunities to explore its driving forces and limitations, market size, market segment analysis, regional prospects, key players and the competitive environment. Market Research Report Stem Cell Assay uses the methodology of primary and secondary research to provide accurate data to its readers

Read more
Research 2022, Biobanking Market Size Is Projected to Reach USD 49.46 Billion in 2026 while exhibiting a – Benzinga
stemadminStem Cell ResearchNo comments

Pune, India, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The global Biobanking Market is set to gain traction from the rising integration of innovative technologies in the pre-existing systems. Besides, the introduction to virtual biobanking is set to revolutionize the system by enabling researchers to conduct their studies smoothly, as well as by lowering the time constraints.

Read more

Theme: Illdy.